TRPharm’s long term vision is to become an innovative pharmaceutical company. For this purpose it has been investing into its own novel, biological development project, RPH 104. It has now completed Phase 1 studies and is moving to Phase 2.

In addition, TRPharm is actively pursuing co-development possibilities particularly in rare diseases.

our lead program

rph - 104 phase 1

study You can download the study results here

we would love to share more